Projected Income Statement: CSL Limited

Forecast Balance Sheet: CSL Limited

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,993 -779 10,679 10,526 8,981 8,849 8,070 7,417
Change - -119.51% 1,470.86% -1.43% -14.68% -1.47% -8.8% -8.09%
Announcement Date 8/17/21 8/16/22 8/14/23 8/12/24 8/18/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: CSL Limited

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,196 1,079 1,228 849 636 736.5 819.6 956.6
Change - -9.82% 13.83% -30.86% -25.09% 15.8% 11.29% 16.71%
Free Cash Flow (FCF) 1 2,426 1,550 1,373 1,915 2,925 2,811 3,013 2,895
Change - -36.1% -11.41% 39.48% 52.74% -3.89% 7.18% -3.92%
Announcement Date 8/17/21 8/16/22 8/14/23 8/12/24 8/18/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CSL Limited

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 36.08% 34.04% 29.3% 32.09% 33.11% 33.84% 33.08% 33.39%
EBIT Margin (%) 30.36% 27.72% 23.06% 25.76% 28.72% 29.01% 28.44% 28.64%
EBT Margin (%) 28.74% 26.32% 20.01% 22.8% 23.94% 2.21% 1.05% 25.85%
Net margin (%) 23.04% 21.35% 16.48% 17.85% 19.3% -5.81% 7.57% 19.16%
FCF margin (%) 23.53% 14.67% 10.32% 12.94% 18.8% 18.26% 19.27% 17.82%
FCF / Net Income (%) 102.13% 68.74% 62.58% 72.48% 97.44% -314.6% 254.66% 93.03%

Profitability

        
ROA 14.06% 9.7% 6.79% 7.12% 7.75% 9.3% 10.27% 10.99%
ROE 31.86% 19.64% 14.45% 15.94% 16.36% 17.24% 18.42% 18.74%

Financial Health

        
Leverage (Debt/EBITDA) 1.07x - 2.74x 2.22x 1.74x 1.7x 1.56x 1.37x
Debt / Free cash flow 1.65x - 7.78x 5.5x 3.07x 3.15x 2.68x 2.56x

Capital Intensity

        
CAPEX / Current Assets (%) 11.6% 10.21% 9.23% 5.74% 4.09% 4.78% 5.24% 5.89%
CAPEX / EBITDA (%) 32.16% 30% 31.49% 17.87% 12.35% 14.14% 15.85% 17.63%
CAPEX / FCF (%) 49.32% 69.6% 89.44% 44.33% 21.74% 26.2% 27.2% 33.04%

Items per share

        
Cash flow per share 1 7.939 5.592 5.375 5.697 7.324 7.401 7.902 8.161
Change - -29.57% -3.87% 5.98% 28.56% 1.05% 6.77% 3.28%
Dividend per Share 1 2.22 2.22 2.36 2.64 2.92 2.851 2.925 3.085
Change - 0% 6.31% 11.86% 10.61% -2.36% 2.58% 5.49%
Book Value Per Share 1 18.42 30.26 32.73 35.93 39.93 34.08 34.19 37.56
Change - 64.33% 8.14% 9.79% 11.14% -14.65% 0.31% 9.85%
EPS 1 5.21 4.8 4.53 5.45 6.17 -1.858 3.001 6.512
Change - -7.87% -5.62% 20.31% 13.21% -130.11% 261.49% 117.03%
Nbr of stocks (in thousands) 455,126 481,706 482,372 483,253 484,212 478,912 478,912 478,912
Announcement Date 8/17/21 8/16/22 8/14/23 8/12/24 8/18/25 - - -
1USD
Estimates
2026 *2027 *
P/E -45.5x 28.2x
PBR 2.48x 2.47x
EV / Sales 3.2x 3.1x
Yield 3.37% 3.46%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
84.48USD
Average target price
96.61USD
Spread / Average Target
+14.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CSL Stock
  4. Financials CSL Limited